➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Baxter
Boehringer Ingelheim
Medtronic
Merck

Last Updated: August 7, 2020

DrugPatentWatch Database Preview

Daclizumab - Biologic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Recent Clinical Trials for daclizumab

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Baylor Research InstitutePhase 1
Baylor Health Care SystemPhase 1
Northwestern UniversityPhase 1

See all daclizumab clinical trials

Recent Litigation for daclizumab

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
PFIZER INC. v. ZYDUS PHARMACEUTICALS (USA) INC.2020-02-28
Pfizer Inc. v. Ajanta Pharma Ltd.2019-03-15
Pfizer Inc. v. Teva Pharmaceuticals USA, Inc.2018-12-07

See all daclizumab litigation

PTAB Litigation
PetitionerDate
2017-12-20
2012-09-25

See all daclizumab litigation

Patent Text Search: US Patents for daclizumab

These patents were identified by searching patent claims

Supplementary Protection Certificates for daclizumab

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2016 046 Romania   Start Trial PRODUCT NAME: DACLIZUMAB; NATIONAL AUTHORISATION NUMBER: EU/1/16/1107; DATE OF NATIONAL AUTHORISATION: 20160701; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/16/1107; DATE OF FIRST AUTHORISATION IN EEA: 20160701
0845 Netherlands   Start Trial PRODUCT NAME: DADIZUMAB; REGISTRATION NO/DATE: EU/1/16/1107 20160705
16/052 Ireland   Start Trial PRODUCT NAME: DACLIZUMAB; REGISTRATION NO/DATE: EU/1/16/1107 20160701
2014000022 Germany   Start Trial PRODUCT NAME: OCLACITINIB ODER EIN PHARMAZEUTISCH AKZEPTABLES SALZ DAVON; REGISTRATION NO/DATE: EU/2/13/154 20130912
0846 Netherlands   Start Trial PRODUCT NAME: DADIZUMAB; REGISTRATION NO/DATE: EU/1/16/1107 20160705
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Merck
Moodys
Express Scripts
McKesson
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.